Linkage and association studies of the lipoprotein lipase gene with postheparin plasma lipase activities, body fat, and plasma lipid and lipoprotein concentrations:: The HERITAGE Family Study

被引:32
作者
Garenc, C
Pérusse, L
Gagnon, J
Chagnon, YC
Bergeron, J
Després, JP
Province, MA
Leon, AS
Skinner, JS
Wilmore, JH
Rao, DC
Bouchard, C
机构
[1] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA
[2] Univ Laval, Med Res Ctr, Div Kinesiol, Phys Act Sci Lab, St Foy, PQ G1K 7P4, Canada
[3] Univ Laval, Med Res Ctr, Lipid Res Ctr, St Foy, PQ G1K 7P4, Canada
[4] Univ Minnesota, Sch Kinesiol & Leisure Studies, Minneapolis, MN USA
[5] Indiana Univ, Dept Kinesiol, Bloomington, IN 47405 USA
[6] Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX USA
[7] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA
[8] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA
[9] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2000年 / 49卷 / 04期
关键词
D O I
10.1016/S0026-0495(00)80004-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lipoprotein lipase (LPL) is responsible for the hydrolysis of triglyceride (TG)-rich lipoproteins. The aims of the present study were (1) to test for potential linkages (sib-pair method) between postheparin plasma lipase (lipoprotein and hepatic lipase) activities, body fatness, plasma lipid concentrations, and LPL polymorphisms (Ser447Ter and a tetranucleotide repeat) and microsatellite markers flanking the LPL locus (D8S261 and D8S258); and (2) to investigate associations between the LPL Ser447Ter (S447X) polymorphism and these phenotypes. Data on 190 parents and 312 adult offspring from 99 Caucasian families participating in the HERITAGE Family Study were available for this study. Data were adjusted for the effects of age within sex, end lipases, lipid variables, and abdominal visceral fat were further adjusted for fat mess. A suggestive linkage was observed only between the S447X polymorphism and very-low-density (VLDL)-apolipoprotein B (apo B) (332 sib-pairs, P = .013). The S447X polymorphism was not associated with body fat phenotypes or postheparin plasma LPL (PH-LPL) activity (men, P = .19; women, P = .47). In contrast, the X447 allele carriers had lower plasma TG (men and women, P = .01), VLDL-TG (men and women. P = .01), and VLDL-apo B (men and women, P = .009). The relationships between the X447 allele end plasma TG, VLDL-TG, and VLDL-apo B in both genders were observed in obese (body mass index [BMI] greater than or equal to 30 kg/m(2)) but not in normal-weight (BMI < 25 kg/m(2)) subjects. Thus, the S447X polymorphism of the LPL gene is not associated with body fatness and postheparin plasma lipase activities. However, the obese carriers of the X447 allele have plasma TG, VLDL-TG, and plasma cholesterol/high-density lipoprotein cholesterol (HDL-C) levels equivalent to those of normal-weight sedentary adults. Copyright (C) 2000 by W.B. Saunders Company.
引用
收藏
页码:432 / 439
页数:8
相关论文
共 42 条
  • [1] LIPOPROTEIN-LIPASE ENHANCES THE BINDING OF CHYLOMICRONS TO LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN
    BEISIEGEL, U
    WEBER, W
    BENGTSSONOLIVECRONA, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) : 8342 - 8346
  • [2] BENZEEV O, 1983, J BIOL CHEM, V258, P3632
  • [3] BOUCHARD C, 1995, MED SCI SPORT EXER, V27, P721
  • [4] SUR UN DOSAGE RAPIDE DU CHOLESTEROL LIE AUX ALPHA-LIPOPROTEINES ET AUX BETA-LIPOPROTEINES DU SERUM
    BURSTEIN, M
    SAMAILLE, J
    [J]. CLINICA CHIMICA ACTA, 1960, 5 (04) : 609 - 609
  • [5] DIONNE FT, 1991, MED SCI SPORT EXER, V23, P177
  • [6] FAUSTINELLA F, 1991, J BIOL CHEM, V266, P14418
  • [7] ASSESSMENT OF ADIPOSE-TISSUE DISTRIBUTION BY COMPUTED AXIAL-TOMOGRAPHY IN OBESE WOMEN - ASSOCIATION WITH BODY DENSITY AND ANTHROPOMETRIC MEASUREMENTS
    FERLAND, M
    DESPRES, JP
    TREMBLAY, A
    PINAULT, S
    NADEAU, A
    MOORJANI, S
    LUPIEN, PJ
    THERIAULT, G
    BOUCHARD, C
    [J]. BRITISH JOURNAL OF NUTRITION, 1989, 61 (02) : 139 - 148
  • [8] Galton D J, 1996, Z Gastroenterol, V34 Suppl 3, P56
  • [9] GARFINKEL AS, 1987, PLASMA LIPOPROTEINS, P335
  • [10] GIDEZ LI, 1982, J LIPID RES, V23, P1206